🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Relatively little information is available about the effects of salmeterol/...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11
Trial ID
NCT00549146
One in every 11 children in the United Kingdom (UK) has asthma. Children wi...
Status
Completed
Location
Brighton & Sussex University Hospitals NHS Trust
Start Date
2016-02
Trial ID
NCT02758873
Treatments Being Tested
The hypothesis to be tested of this study is that treatment with fluticason...
Status
Terminated
Location
University Medical Center Groningen
Start Date
2000-04
Trial ID
NCT00158847
Treatments Being Tested
A non-interventional study to assess the clinical effectiveness of Salmeter...
Status
Completed
Location
Lungenpraxis
Start Date
2019-01-16
Trial ID
NCT03755544
The purpose of this study is to understand why patients in the World Trade ...
Status
Completed
Location
New York University School of Medicine
Start Date
2014-04-09
Trial ID
NCT02024204
The purpose of this study is to determine whether Symbicort dosed according...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252863
Treatments Being Tested
Study to compare the metabolic and electrolyte effects of a single oral dos...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT02256722
Treatments Being Tested
The purpose of this study is to investigate the effectiveness of inhaled mo...
Status
Completed
Location
Faculty of Medicine, Ramathibodi Hospital
Start Date
2015-05
Trial ID
NCT02415179
Treatments Being Tested
Evaluate the additive role of zileuton 600mg qid to clinically stable asthm...
Status
Completed
Location
Arthur F Gelb Medical Corporation
Start Date
2005-09
Trial ID
NCT00575861
Treatments Being Tested
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2018-11-20
Trial ID
NCT03751202
Treatments Being Tested